1. Characters of the strain are genetically identified. 2. Types of probiotic blends/premixes could be provided based on the clients' requirements. 3. Tyndalized (Heat-Sterilized) specifications could be provided based on clients' requirements. 4. Complete data sheet is available based on the clients' requirements. 6. For research use only. Not intended for food, diagnostics, therapeutic or any in vivo human use.
Target Introduction
Introduction
Prevotella copri is a gram-negative rods bacteria, belonging to the phylum Bacteroidetes They are anaerobic and nonspore-forming. Prevotella copri is an intestinal bacteria, and its anaerobic qualities allows it to grow successfully in the human gut and intestines. Colonies on EG agar plates after 48 h incubation at 37°C under 100% CO2 are white, circular and convex. Optimum temperature for growth is 37°C. Growth is inhibited on Bacteroides bile aesculin agar. Indole and aesculin is hydrolysed. No activity is detected for urease and gelatin is not hydrolysed. As a potential next generation probiotic, Prevotella copri was found to improve aberrant glucose tolerance syndromes and enhance hepatic glycogen storage in animals via the production of succinate, a tricarboxylic acid (TCA) cycle intermediate fermented from uptake of dietary fibers, that is responsible for glucose homeostasis through modulating intestinal gluconeogenesis. Recent studies have shown a correlation between Prevotella copri and the development of rheumatoid arthritis.
Alternative Names
Prevotella copri; P. copri
Customer Reviews
Click the button below to contact us or submit your feedback about this product.
Online Inquiry
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
